SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12297576
Source:
http://linkedlifedata.com/resource/pubmed/id/12297576
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0018787
,
umls-concept:C0026259
,
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0282248
,
umls-concept:C0332281
,
umls-concept:C0879626
,
umls-concept:C2349943
pubmed:issue
6
pubmed:dateCreated
2002-9-25
pubmed:abstractText
Mitoxantrone (MITO) is associated with dose-related cardiotoxicity when administered concomitantly with other cytotoxic agents with or without radiotherapy for leukemia and solid tumors.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0028-3878
pubmed:author
pubmed-author:ButineM DMD
,
pubmed-author:EdanGG
,
pubmed-author:EisenmanSS
,
pubmed-author:GhalieR GRG
,
pubmed-author:GonsetteR ERE
,
pubmed-author:GoodkinD EDE
,
pubmed-author:HartungH PHP
,
pubmed-author:LaurentMM
,
pubmed-author:MauckJJ
pubmed:issnType
Print
pubmed:day
24
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
909-13
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12297576-Adolescent
,
pubmed-meshheading:12297576-Adult
,
pubmed-meshheading:12297576-Age Factors
,
pubmed-meshheading:12297576-Aged
,
pubmed-meshheading:12297576-Chi-Square Distribution
,
pubmed-meshheading:12297576-Confidence Intervals
,
pubmed-meshheading:12297576-Drug Administration Schedule
,
pubmed-meshheading:12297576-Female
,
pubmed-meshheading:12297576-Heart Failure
,
pubmed-meshheading:12297576-Humans
,
pubmed-meshheading:12297576-Male
,
pubmed-meshheading:12297576-Middle Aged
,
pubmed-meshheading:12297576-Mitoxantrone
,
pubmed-meshheading:12297576-Multicenter Studies as Topic
,
pubmed-meshheading:12297576-Multiple Sclerosis
,
pubmed-meshheading:12297576-Retrospective Studies
,
pubmed-meshheading:12297576-Sex Factors
,
pubmed-meshheading:12297576-Ventricular Dysfunction, Left
pubmed:year
2002
pubmed:articleTitle
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.
pubmed:affiliation
Immunex Corp., Seattle, WA 98101, USA.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't
,
Meta-Analysis